Oriana Papin-Zoghbi emerges as a trailblazing force not only in women’s health but also in global health. As a successful entrepreneur and a recipient of the Top 100 Inc. Female Founders Award, Papin-Zoghbi’s journey is marked by significant contributions to HPV and cervical cancer screening in Africa, where she collaborated with QIAGEN and the Bill and Melinda Gates Foundation.
“Oriana’s dedication to addressing healthcare disparities in underserved regions underscores her commitment to making a meaningful difference on a global scale,” said her colleagues. “Her ability to rally support for causes she champions reflects not only her business acumen but also her passion for creating a lasting impact in the healthcare landscape.”
Papin-Zoghbi’s testament to the entrepreneurial spirit continues as she leads AOA Dx with partners who have amassed a wealth of experience totaling more than 30 years.
AOA Dx is a diagnostics firm at the forefront of a groundbreaking frontier in early-stage cancer detection for women, harnessing the power of glycolipids and its proprietary biomarker technology. The trailblazing work has given rise to the revolutionary tumor marker ganglioside platform, GlycoLocate, which stands as a beacon in the quest for life-saving early cancer detection.
Under Papin-Zoghbi’s guidance, the firm is actively developing AKRIVIS GD, an early-stage liquid biopsy test specifically tailored for ovarian cancer.
“In our pursuit of longevity and vitality for women, AOA is not just a company; it’s a beacon of hope and innovation,” said Papin-Zoghbi. “Our ambitious plan unfolds through the development of novel diagnostics in oncology, pioneering a paradigm shift in early disease detection.”
As a leader in the diagnostics and healthcare industries, Papin-Zoghbi said she relies on the art of persuasion that stems from her experience in sales. “Whether it’s rallying a team around a shared goal or convincing stakeholders of a strategic initiative, my ability to effectively communicate and persuade plays a critical role,” she said. “This superpower extends beyond mere sales pitches; it’s about building consensus, fostering collaboration and inspiring collective action.”
Using the art of persuasion has earned both Papin-Zoghbi and the firm high honors. Her notable achievements extend to receiving the Women’s Health Innovation Summit Award, the Massachusetts Life Sciences Center Next Gen Award and the Wave Summit’s Emerging Women Founder in Bio Award. AOA has been recognized with the Eddies Award, highlighting outstanding contributions to the life sciences industry.
She also taps into humility as a leader. “Humility is a key attribute that helps leaders build genuine relationships and foster a positive organizational culture,” said Papin-Zoghbi. “Humble leaders value the contributions of others, recognize the importance of continuous learning and are open to feedback; this trait enables leaders to create an inclusive environment where team members feel heard and valued.”
